ArticleNature2016
Immunotherapy: Cancer vaccine triggers antiviral-type defences.
Article in Nature, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Article
- Nanodiamonds Interact with Primary Human Macrophages and Dendritic Cells Evoking a Vigorous Interferon Response.ACS nano · 2025Article
- Harnessing the Power of Nanocarriers to Exploit the Tumor Microenvironment for Enhanced Cancer Therapy.Pharmaceuticals (Basel, Switzerland) · 2025Review
- Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial.Nature medicine · 2025Article
- Shortwave-infrared-light-emitting probes for the in vivo tracking of cancer vaccines and the elicited immune responses.Nature biomedical engineering · 2024Article
- Tumor Microenvironment Regulation and Cancer Targeting Therapy Based on Nanoparticles.Journal of functional biomaterials · 2023Review
- Insight into lipid-based nanoplatform-mediated drug and gene delivery in neuro-oncology and their clinical prospects.Frontiers in oncology · 2023Review
- Engineering Therapeutic Strategies in Cancer Immunotherapy via Exogenous Delivery of Toll-like Receptor Agonists.Pharmaceutics · 2021Review
- Emerging glyco-based strategies to steer immune responses.The FEBS journal · 2021Review
- Cancer immunoediting: A game theoretical approach.In silico biology · 2021Article
- Article
- Computational Prediction and Validation of Tumor-Associated Neoantigens.Frontiers in immunology · 2020Review
- Autologous hybrid cell fusion vaccine in a spontaneous intermediate model of breast carcinoma.Journal of veterinary science · 2019Article
- Cancer Vaccine Immunotherapy with RNA-Loaded Liposomes.International journal of molecular sciences · 2018Review
- Towards superior dendritic-cell vaccines for cancer therapy.Nature biomedical engineering · 2018Article
- Co-delivery of tumor antigen and dual toll-like receptor ligands into dendritic cell by silicon microparticle enables efficient immunotherapy against melanoma.Journal of controlled release : official journal of the Controlled Release Society · 2018Article
- The Antibody Repertoire of Colorectal Cancer.Molecular & cellular proteomics : MCP · 2017Article
- Engineering and physical sciences in oncology: challenges and opportunities.Nature reviews. Cancer · 2017Review
- A new marine-derived sulfoglycolipid triggers dendritic cell activation and immune adjuvant response.Scientific reports · 2017Article
- Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors.Science (New York, N.Y.) · 2017Article
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
27281206What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.